The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 10, 2024

Study Completion Date

December 1, 2024

Conditions
Diastolic DysfunctionObesity
Interventions
DRUG

Metformin

The intervention will consist in giving metformin starting with 500 mg once daily (at breakfast) during the first week; if well tolerated, the dose was progressively increased to 500 mg twice daily (at breakfast and dinner) during week 2, to 1000 mg at breakfast and 500 mg at dinner during week 3, in order to reach the target dose of 1000 mg twice daily (at breakfast and dinner)

Trial Locations (2)

Unknown

RECRUITING

Cairo University Hospitala, Cairo

NOT_YET_RECRUITING

Cairo University Hospitals, Cairo

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

Sara ElAdawy

OTHER